Open-label BV-araU [sorivudine] treatment of pediatric HIV-infected patients with cutaneous, visceral, or ocular varicella-zoster viral disease who have failed or are intolerant of standard therapy
Latest Information Update: 18 Jan 2007
At a glance
- Drugs Sorivudine (Primary)
- Indications Varicella zoster virus infections
- Focus Therapeutic Use
- 19 Dec 2006 Status change
- 31 Oct 2005 New trial record.